000 | 01455 a2200409 4500 | ||
---|---|---|---|
005 | 20250513102102.0 | ||
264 | 0 | _c19961211 | |
008 | 199612s 0 0 eng d | ||
022 | _a0091-2700 | ||
024 | 7 |
_a10.1002/j.1552-4604.1996.tb04183.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTroy, S M | |
245 | 0 | 0 |
_aPharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithium. _h[electronic resource] |
260 |
_bJournal of clinical pharmacology _cFeb 1996 |
||
300 |
_a175-81 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntidepressive Agents, Second-Generation _xadverse effects |
650 | 0 | 4 |
_aCyclohexanols _xadverse effects |
650 | 0 | 4 | _aDesvenlafaxine Succinate |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLithium _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
650 | 0 | 4 | _aVenlafaxine Hydrochloride |
700 | 1 | _aParker, V D | |
700 | 1 | _aHicks, D R | |
700 | 1 | _aBoudino, F D | |
700 | 1 | _aChiang, S T | |
773 | 0 |
_tJournal of clinical pharmacology _gvol. 36 _gno. 2 _gp. 175-81 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/j.1552-4604.1996.tb04183.x _zAvailable from publisher's website |
999 |
_c8846559 _d8846559 |